Min-Tze LIONG
14
5
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
Role: lead
Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study
Role: lead
To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants
Role: lead
Effect of Probiotic on Gut Microbiota in Young Children With Functional Constipation
Role: lead
Study on the Efficacy of Probiotics in the Treatment of Childhood Obesity and Their Effects on Gut Microbiota
Role: lead
Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections
Role: lead
The Effect of Probiotics on Gut Microbiota Changes in Healthy Chinese Adults During Short-Term European Travel: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Role: lead
Postbiotic as Adjunct Treatment for Vaginal Candidiasis
Role: lead
Modulation of Gut Microbiota by Probiotic in Children
Role: lead
Probiotic Modulates Vaginal Microflora
Role: lead
Efficacy of Probiotic Against Functional Constipation
Role: lead
Effects of Probiotic Against Respiratory & Gastrointestinal Illnesses in Children
Role: lead
Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms
Role: lead
The Efficacy of Probiotic Compared With Placebo Commitment Therapy for Treatment of Major Depressive Disorder
Role: lead
All 14 trials loaded